HMGB1 and peripheral arterial disease: However, in relation to the results of discussed evidences (Table 2), further research is needed to clarify the role of HMGB1 in PAD, and other clinical studies are needed to evaluate the role of this protein in patients with PAD subjected to revascularization of the lower limb in terms of outcome.